Published Date：Mar.2021
Industry：Pharma & Healthcare
Pages：107 Table Number：122
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Pegfilgrastim market in this environment. In terms of revenue, this research report indicated that the global Pegfilgrastim market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Pegfilgrastim industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Amgen aims at producing XX K Units Pegfilgrastim in 2020, with XX % production to take place in global market, Mylan accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Pegfilgrastim Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Pegfilgrastim Market? Amgen Mylan Coherus BioSciences ... Major Type of Pegfilgrastim Covered in XYZResearch report: Pegfilgrastim Pegfilgrastim Biosimilar Application Segments Covered in XYZResearch Market Hospital Drug store Application 3 For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Pegfilgrastim Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Pegfilgrastim -Product Introduction and Major Manufacturers 1.1.2 Pegfilgrastim Biosimilar -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Pegfilgrastim Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Pegfilgrastim Market 3.1.1 Top Companies leading Pegfilgrastim Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Pegfilgrastim Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Pegfilgrastim Market 3.2.1 Top Companies leading Pegfilgrastim Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Pegfilgrastim Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Pegfilgrastim Market 3.3.1 Top Companies leading Pegfilgrastim Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Pegfilgrastim Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Pegfilgrastim Market 3.4.1 Top Companies leading Pegfilgrastim Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Pegfilgrastim Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Pegfilgrastim Market 3.5.1 Top Companies leading Pegfilgrastim Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Pegfilgrastim Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Pegfilgrastim Market 3.6.1 Top Companies leading Pegfilgrastim Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Pegfilgrastim Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Pegfilgrastim Market 3.7.1 Top Companies leading Pegfilgrastim Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Pegfilgrastim Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Pegfilgrastim Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Pegfilgrastim Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Pegfilgrastim Sales and Growth Rate (2021-2027) 5.2 Global Pegfilgrastim Sales Value and Growth Rate (2021-2027) 6 Pegfilgrastim Competitive Analysis 6.1 Amgen 6.1.1 Amgen Company Profiles 6.1.2 Amgen Product Introduction 6.1.3 Amgen Pegfilgrastim Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 Mylan 6.2.1 Mylan Company Profiles 6.2.2 Mylan Product Introduction 6.2.3 Mylan Pegfilgrastim Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 Coherus BioSciences 6.3.1 Coherus BioSciences Company Profiles 6.3.2 Coherus BioSciences Product Introduction 6.3.3 Coherus BioSciences Pegfilgrastim Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Pegfilgrastim Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Pegfilgrastim Sales (K Unit) by Type (2026-2027) Figure Global Pegfilgrastim Sales (K Unit) and Growth Rate (2026-2027) Figure Global Pegfilgrastim Sales Market Share (%) by Type (2019 -2020) Table Global Pegfilgrastim Sales Value (Million USD) by Type (2026-2027) Figure Global Pegfilgrastim Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Pegfilgrastim Sales Value Market Share (%) by Type (2019-2020) Table Global Pegfilgrastim Sales (K Unit) by Application (2026-2027) Table China Pegfilgrastim Sales (K Unit) of Major Company (2016-2021) Table China Pegfilgrastim Sales Market Share of Major Company (2016-2021) Table China Pegfilgrastim Sales Value (Million USD) of Major Company (2016-2021) Figure China Pegfilgrastim Sales Value (Million USD) and Growth Rate (2016-2021) Table China Pegfilgrastim Sales Value Share of Major Company (2016-2021) Table China Pegfilgrastim Price (USD/Unit), by Type (2019-2020) Table China Pegfilgrastim Sales (Unit) by Type (2026-2027) Figure China Pegfilgrastim Sales (Unit) by Type (2026-2027) Table EU Pegfilgrastim Sales (K Unit) of Major Company (2016-2021) Table EU Pegfilgrastim Sales Market Share of Major Company (2016-2021) Table EU Pegfilgrastim Sales Value (Million USD) of Major Company (2016-2021) Figure EU Pegfilgrastim Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Pegfilgrastim Sales Value Share of Major Company (2016-2021) Table EU Pegfilgrastim Price (USD/Unit), by Type (2019-2020) Table EU Pegfilgrastim Sales (Unit) by Type (2026-2027) Figure EU Pegfilgrastim Sales (Unit) by Type (2026-2027) Table USA Pegfilgrastim Sales (K Unit) of Major Company (2016-2021) Table USA Pegfilgrastim Sales Market Share of Major Company (2016-2021) Table USA Pegfilgrastim Sales Value (Million USD) of Major Company (2016-2021) Figure USA Pegfilgrastim Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Pegfilgrastim Sales Value Share of Major Company (2016-2021) Table USA Pegfilgrastim Price (USD/Unit), by Type (2019-2020) Table USA Pegfilgrastim Sales (Unit) by Type (2026-2027) Figure USA Pegfilgrastim Sales (Unit) by Type (2026-2027) Table Japan Pegfilgrastim Sales (K Unit) of Major Company (2016-2021) Table Japan Pegfilgrastim Sales Market Share of Major Company (2016-2021) Table Japan Pegfilgrastim Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Pegfilgrastim Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Pegfilgrastim Sales Value Share of Major Company (2016-2021) Table Japan Pegfilgrastim Price (USD/Unit), by Type (2019-2020) Table Japan Pegfilgrastim Sales (Unit) by Type (2026-2027) Figure Japan Pegfilgrastim Sales (Unit) by Type (2026-2027) Table India Pegfilgrastim Sales (K Unit) of Major Company (2016-2021) Table India Pegfilgrastim Sales Market Share of Major Company (2016-2021) Table India Pegfilgrastim Sales Value (Million USD) of Major Company (2016-2021) Figure India Pegfilgrastim Sales Value (Million USD) and Growth Rate (2016-2021) Table India Pegfilgrastim Sales Value Share of Major Company (2016-2021) Table India Pegfilgrastim Price (USD/Unit), by Type (2019-2020) Table India Pegfilgrastim Sales (Unit) by Type (2026-2027) Figure India Pegfilgrastim Sales (Unit) by Type (2026-2027) Table Southeast Asia Pegfilgrastim Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Pegfilgrastim Sales Market Share of Major Company (2016-2021) Table Southeast Asia Pegfilgrastim Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Pegfilgrastim Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Pegfilgrastim Sales Value Share of Major Company (2016-2021) Table Southeast Asia Pegfilgrastim Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Pegfilgrastim Sales (Unit) by Type (2026-2027) Figure Southeast Asia Pegfilgrastim Sales (Unit) by Type (2026-2027) Table South America Pegfilgrastim Sales (K Unit) of Major Company (2016-2021) Table South America Pegfilgrastim Sales Market Share of Major Company (2016-2021) Table South America Pegfilgrastim Sales Value (Million USD) of Major Company (2016-2021) Figure South America Pegfilgrastim Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Pegfilgrastim Sales Value Share of Major Company (2016-2021) Table South America Pegfilgrastim Price (USD/Unit), by Type (2019-2020) Table South America Pegfilgrastim Sales (Unit) by Type (2026-2027) Figure South America Pegfilgrastim Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Pegfilgrastim Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Pegfilgrastim Figure Cost Structure of Pegfilgrastim in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Pegfilgrastim Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Pegfilgrastim Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table Amgen Profiles Table Amgen Pegfilgrastim Product Introduction Table Amgen Pegfilgrastim Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Amgen SWOT Analysis Table Mylan Profiles Table Mylan Pegfilgrastim Product Introduction Table Mylan Pegfilgrastim Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Mylan SWOT Analysis Table Coherus BioSciences Profiles Table Coherus BioSciences Pegfilgrastim Product Introduction Table Coherus BioSciences Pegfilgrastim Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
